The price of cabozantinib varies significantly depending on factors such as dosage, regional policies, and purchasing channels. Currently, this drug i···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 159
The U.S. Food and Drug Administration (FDA) recently announced conventional approval for Johnson & Johnson's Sirturo (bedaquiline) as part of ···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 184
Previously, Genentech, a subsidiary of Roche, announced that its Valcyte (valganciclovir hydrochloride) had been approved by the U.S. Food and Drug Ad···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 184
The price of anagrelide is affected by factors such as specifications, region, and medical insurance policies. In the domestic market, the price typic···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 187
The price of anagrelide (anagrelide hydrochloride) varies depending on its strength, dosage form, purchase channel, and region; imported versions may ···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 186
The price of anagrelide (anagrelide hydrochloride) varies depending on its strength, dosage form, purchase channel, and region; imported versions may ···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 177
The price of ibrutinib is affected by dosage, region, and medical insurance policies. The specific price per box usually depends on the doctor's p···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 192
The price of ibrutinib varies significantly depending on the region and version purchased. This variation primarily stems from the influence of health···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 190
Ibrutinib is a targeted drug used to treat hematologic malignancies such as lymphoma and leukemia, and it belongs to the BTK inhibitor class. Its pric···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 189
Takeda Pharmaceutical recently presented updated data from a Phase 1/2 clinical trial of its oral targeted anticancer drug mobocertinib (TAK-788) for ···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 177
Takeda Pharmaceutical recently announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review its New Drug Applic···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 181
Summary: EGFR Exon20ins+ non-small cell lung cancer (NSCLC) is an extremely rare cancer, primarily affecting young adults and non-smokers. Its prognos···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 177
On September 15, 2021, Takeda Pharmaceutical Company of Japan announced accelerated approval from the FDA for Exkivity (mobocertinib) for the treatmen···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 165
Recently, the UK's National Institute for Health and Care Excellence (NICE) released its final guidelines, recommending Exkivity (Mobocertinib) fo···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 171
The price of Upadacitinib varies by region, dosage specification, and purchasing channel. In domestic public hospitals or formal pharmacies, it is gen···【Read More】
Update: 2026-03-20Source: Haiou HealthViews: 197
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos